跳至主要内容
临床试验/CTRI/2009/091/000056
CTRI/2009/091/000056已完成3 期

A comparative clinical trial for the evaluation of the efficacy and safety of FDC of Lornoxicam (4 mg) and Paracetamol (500 mg)with Lornoxicam (4 mg) alone for short term treatment of mild to moderate pain associated with extra articular inflammation

Aristo Pharmaceuticals pvt ltd Mumbai0 个研究点目标入组 201 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
201